Please assess the completion status of the following clinical trial:

Trial Title: LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Have no previous or present history of a DSM-IV psychiatric or substance dependence disorder within the previous year, according to the Structured Clinical Interview for Diagnosis- DSM-IV (SCID)-Non-Patient Version;~2. Are within 5 years of last menstrual period (LMP);~3. Have a follicular stimulating hormone level (FSH) of 20 IU/ml;~4. Are able to give written informed consent;~5. Must have clear urine toxicology screen upon recruitment;~6. Are fluent in written and spoken English;~7. Are right-handed;~8. Negative urine pregnancy test if still menstruating.~Exclusion Criteria:~1. Mini-mental status exam score of less than or equal to 24;~2. Presence of a psychiatric disorder within previous year or a life time history of ADHD or psychotic disorder including bipolar disorder, schizoaffective disorder, and schizophrenia;~3. Lifetime history of drug addiction or abuse, except nicotine;~4. Regular use of other psychotropic medication;~5. Regular use (more than once a week) of alcohol that is less than 3 drinks/day;~6. Presence of a contraindication to treatment with stimulant medication unless the condition is controlled with medication; this would include the presence of uncontrolled hypertension, coronary disease, atrial fibrillation, and arrhythmia;~7. History of seizures;~8. History of cardiac disease including known cardiac defect or conduction abnormality;~9. Abnormal electrocardiogram during screening;~10. Use of estrogen therapy within previous 2 months;~11. Current pregnancy or planning to become pregnant;~12. Metallic implant;~13. Claustrophobia.

- Gender: FEMALE
- Minimum Age: 45 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Lisdexamfetamine (Type: ACTIVE_COMPARATOR): Lisdexamfetamine or Vyvanse
- Sugar Pill (Type: PLACEBO_COMPARATOR): Placebo pill, capsules

Based on this trial design, predict the completion outcome and termination type (if applicable).